“The negative outlook reflects Moody’s view that MHS will face challenges in achieving better operating cash flow margins as well as targeted days cash and cash to debt measures over the next 12-18 months,” the rating agency said.
Operating improvements in fiscal 2024 should lead to nearing the target of 100 days of cash on hand, management said, according to Moody’s.
Moody’s affirmed Montefiore’s “Baa3” rating because of the 10-hospital system’s leading market share in the Bronx, its clinical expertise, and its flagship status as the primary teaching hospital for Albert Einstein College of Medicine.
Montefiore Health System, which reported an operating loss of $98.5 million in 2022, said March 2 it received an anonymous $100 million donation for the Albert Einstein College.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
